Recursion Pharmaceuticals: Q3 Earnings Snapshot

Barchart · 1d ago

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Monday reported a loss of $119 million in its third quarter.

On a per-share basis, the Salt Lake City-based company said it had a loss of 22 cents.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.

The biotechnology company posted revenue of $18.6 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $10.9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX